SAB Biotherapeutics, Inc. (SABS)
3.715
-0.08
(-1.98%)
USD |
NASDAQ |
Aug 31, 16:00
3.715
0.00 (0.00%)
After-Hours: 20:00
SAB Biotherapeutics Market Cap : 310.18M for Aug. 31, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 316.44M |
| August 27, 2026 | 328.13M |
| August 26, 2026 | 323.95M |
| August 25, 2026 | 318.11M |
| August 24, 2026 | 302.24M |
| August 21, 2026 | 315.60M |
| August 20, 2026 | 308.92M |
| August 19, 2026 | 315.60M |
| August 18, 2026 | 316.44M |
| August 17, 2026 | 314.77M |
| August 14, 2026 | 308.92M |
| August 13, 2026 | 313.10M |
| August 12, 2026 | 317.27M |
| August 11, 2026 | 313.93M |
| August 10, 2026 | 315.60M |
| August 07, 2026 | 325.62M |
| August 06, 2026 | 321.45M |
| August 05, 2026 | 314.77M |
| August 04, 2026 | 321.45M |
| August 03, 2026 | 287.07M |
| July 31, 2026 | 270.41M |
| July 30, 2026 | 269.65M |
| July 29, 2026 | 263.59M |
| July 28, 2026 | 261.32M |
| July 27, 2026 | 260.56M |
| Date | Value |
|---|---|
| July 24, 2026 | 265.86M |
| July 23, 2026 | 271.17M |
| July 22, 2026 | 271.17M |
| July 21, 2026 | 275.71M |
| July 20, 2026 | 265.86M |
| July 17, 2026 | 268.14M |
| July 16, 2026 | 277.60M |
| July 15, 2026 | 274.20M |
| July 14, 2026 | 272.68M |
| July 13, 2026 | 282.53M |
| July 10, 2026 | 289.34M |
| July 09, 2026 | 299.95M |
| July 08, 2026 | 285.56M |
| July 07, 2026 | 295.40M |
| July 06, 2026 | 296.92M |
| July 02, 2026 | 296.92M |
| July 01, 2026 | 293.89M |
| June 30, 2026 | 295.40M |
| June 29, 2026 | 295.40M |
| June 26, 2026 | 287.83M |
| June 25, 2026 | 293.13M |
| June 24, 2026 | 290.86M |
| June 23, 2026 | 293.13M |
| June 22, 2026 | 297.68M |
| June 18, 2026 | 302.98M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.63B |
| Oncolytics Biotech, Inc. | 105.07M |
| Sangamo Therapeutics, Inc. | 66.49M |
| Sarepta Therapeutics, Inc. | 2.221B |
| Anixa Biosciences, Inc. | 114.15M |
Market Cap Related Metrics
| Price to Book Value | 1.444 |
| Price | 3.715 |
| Earnings Yield | -44.69% |